Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

The Circulating Cell-Free Genome Atlas Study

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 25.10.18
Views: 537

Dr Minetta C. Liu - Mayo Clinic, Rochester, Minessota

Dr Minetta C. Liu speaks with ecancer at ESMO 2018 in Munich about the circulating cell-free genome atlas study.

The study is an effort to collect blood specimens in all patients and tissue specimens in cancer patients to help develop a multi-cancer blood cancer screening detection test.

Dr Liu explains that they discovered in the test set, presented at ESMO, that they are able to classify cancer versus non-cancer with excellent sensitivity in the patients that cancer should be identifiable early.

ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.

Related videos

follow us

Immuno-oncology advances in cancer treatment e-learning

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation